Operating CF
$295M
Capex
-$25.3M
Free Cash Flow
$270M
FCF Margin
+91.4%
Cash flow waterfall for Bio-Techne (TECH) — TTM through Q1 2026
Free cash flow: $270M
Cash flow breakdown for Bio-Techne (TECH) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Operating Cash Flow | $295M | $295M |
| Capital Expenditure | -$25.3M | $270M |
| Free Cash Flow | $270M | $270M |
| Acquisitions | $5.28M | $275M |
| Other Investing | $9.26M | $284M |
| Share Buybacks | -$100M | $184M |
| Dividends Paid | -$49.8M | $134M |
| Net Debt Change | -$130M | $4.23M |
| Other Financing | $53.5M | $57.8M |
| Forex Effect | $11.4M | $69.1M |
| Net Cash Increase | $69.1M | $69.1M |
- Operating Cash Flow$295M
- Capital Expenditure-$25.3M
- Free Cash Flow$270M
- Acquisitions$5.28M
- Other Investing$9.26M
- Share Buybacks-$100M
- Dividends Paid-$49.8M
- Net Debt Change-$130M
- Other Financing$53.5M
- Forex Effect$11.4M
- Net Cash Increase$69.1M
Want to see what drove the FCF change?Free Cash Flow Bridge
Frequently asked questions
Data & methodology
Bio-Techne (TECH) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
- Buybacks1.23% TTM
- Dividend Profile0.45% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History3 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.